| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647991 | Journal of the American Academy of Dermatology | 2017 | 14 Pages |
Abstract
Measuring CXCL9 directly in the skin might be effective in clinical trials as an early marker of treatment response. Additionally, use of the modified suction-blister technique supports investigation of inflammatory skin diseases using powerful tools like flow cytometry and protein quantification.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
James P. BS, Mehdi MD, Maggi MBBCh, MSc, Jillian M. PhD, John E. MD, PhD,